DK2262525T3 - Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme - Google Patents
Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de sammeInfo
- Publication number
- DK2262525T3 DK2262525T3 DK09720761.7T DK09720761T DK2262525T3 DK 2262525 T3 DK2262525 T3 DK 2262525T3 DK 09720761 T DK09720761 T DK 09720761T DK 2262525 T3 DK2262525 T3 DK 2262525T3
- Authority
- DK
- Denmark
- Prior art keywords
- apoaequorin
- methods
- same
- containing compositions
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3544308P | 2008-03-11 | 2008-03-11 | |
PCT/US2009/036767 WO2009114597A1 (en) | 2008-03-11 | 2009-03-11 | Apoaequorin-containing compositions and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2262525T3 true DK2262525T3 (da) | 2013-02-11 |
Family
ID=40627496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09720761.7T DK2262525T3 (da) | 2008-03-11 | 2009-03-11 | Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme |
Country Status (19)
Country | Link |
---|---|
US (1) | US8796213B2 (da) |
EP (1) | EP2262525B1 (da) |
JP (1) | JP5508294B2 (da) |
KR (1) | KR101643662B1 (da) |
CN (2) | CN101969979A (da) |
AU (1) | AU2009223010B2 (da) |
BR (1) | BRPI0909435A2 (da) |
CA (1) | CA2717322C (da) |
CY (1) | CY1114366T1 (da) |
DK (1) | DK2262525T3 (da) |
ES (1) | ES2401754T3 (da) |
HR (1) | HRP20130205T1 (da) |
IL (1) | IL207827A (da) |
MX (1) | MX2010009753A (da) |
NZ (1) | NZ588437A (da) |
PL (1) | PL2262525T3 (da) |
PT (1) | PT2262525E (da) |
SI (1) | SI2262525T1 (da) |
WO (1) | WO2009114597A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX350259B (es) * | 2011-11-15 | 2017-08-31 | Quincy Bioscience Llc | Apoaequorina para reducir daño neuronal debido a isquemia. |
CA2886097C (en) * | 2012-09-27 | 2020-07-14 | Quincy Bioscience, Llc | Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions |
MA40959A (fr) * | 2014-11-11 | 2017-09-19 | Quincy Bioscience Llc | Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale |
WO2018058050A1 (en) * | 2016-09-23 | 2018-03-29 | Quincy Bioscience, Llc | Apoaequorin and vitamin d-containing compositions and methods of using same |
EP4110312A1 (en) * | 2020-02-24 | 2023-01-04 | Quincy Bioscience, LLC | Apoaequorin and curcumin containing compositions and methods |
EP4199901A1 (en) * | 2020-08-20 | 2023-06-28 | Quincy Bioscience, LLC | Effervescent formulation containing apoaequorin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6447379A (en) * | 1987-08-19 | 1989-02-21 | Chisso Corp | Preparation of calcium-dependent oxygenation enzyme |
US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
CN1324045C (zh) * | 2004-09-22 | 2007-07-04 | 中国科学院海洋研究所 | 从水母中分离的具有抗氧化活性的蛋白及其应用 |
-
2009
- 2009-03-11 NZ NZ588437A patent/NZ588437A/en unknown
- 2009-03-11 PT PT97207617T patent/PT2262525E/pt unknown
- 2009-03-11 SI SI200930489T patent/SI2262525T1/sl unknown
- 2009-03-11 CN CN200980108891XA patent/CN101969979A/zh active Pending
- 2009-03-11 JP JP2010550832A patent/JP5508294B2/ja active Active
- 2009-03-11 KR KR1020107022674A patent/KR101643662B1/ko active IP Right Grant
- 2009-03-11 DK DK09720761.7T patent/DK2262525T3/da active
- 2009-03-11 CN CN201710007032.8A patent/CN106692945A/zh active Pending
- 2009-03-11 MX MX2010009753A patent/MX2010009753A/es active IP Right Grant
- 2009-03-11 CA CA2717322A patent/CA2717322C/en active Active
- 2009-03-11 ES ES09720761T patent/ES2401754T3/es active Active
- 2009-03-11 PL PL09720761T patent/PL2262525T3/pl unknown
- 2009-03-11 WO PCT/US2009/036767 patent/WO2009114597A1/en active Application Filing
- 2009-03-11 AU AU2009223010A patent/AU2009223010B2/en active Active
- 2009-03-11 BR BRPI0909435A patent/BRPI0909435A2/pt not_active Application Discontinuation
- 2009-03-11 US US12/672,463 patent/US8796213B2/en active Active
- 2009-03-11 EP EP09720761A patent/EP2262525B1/en active Active
-
2010
- 2010-08-26 IL IL207827A patent/IL207827A/en active IP Right Grant
-
2013
- 2013-02-13 CY CY20131100128T patent/CY1114366T1/el unknown
- 2013-03-08 HR HRP20130205AT patent/HRP20130205T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2262525B1 (en) | 2012-12-26 |
CA2717322A1 (en) | 2009-09-17 |
PL2262525T3 (pl) | 2013-04-30 |
JP2011513496A (ja) | 2011-04-28 |
KR101643662B1 (ko) | 2016-07-29 |
IL207827A0 (en) | 2010-12-30 |
MX2010009753A (es) | 2010-09-30 |
NZ588437A (en) | 2012-07-27 |
KR20100136494A (ko) | 2010-12-28 |
CA2717322C (en) | 2017-07-11 |
CN106692945A (zh) | 2017-05-24 |
SI2262525T1 (sl) | 2013-03-29 |
US8796213B2 (en) | 2014-08-05 |
CN101969979A (zh) | 2011-02-09 |
HRP20130205T1 (hr) | 2013-04-30 |
JP5508294B2 (ja) | 2014-05-28 |
WO2009114597A1 (en) | 2009-09-17 |
CY1114366T1 (el) | 2016-08-31 |
US20110124562A1 (en) | 2011-05-26 |
IL207827A (en) | 2013-08-29 |
BRPI0909435A2 (pt) | 2017-06-13 |
EP2262525A1 (en) | 2010-12-22 |
PT2262525E (pt) | 2013-01-28 |
AU2009223010A1 (en) | 2009-09-17 |
ES2401754T3 (es) | 2013-04-24 |
AU2009223010B2 (en) | 2014-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2270818T3 (da) | Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten | |
DK2203478T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antistoffer mod sclerostin | |
DK3156069T3 (da) | Sammensætninger, fremgangsmåder, og kits til fremkaldelse af et immunrespons | |
DK2001611T3 (da) | Fremgangsmåde og sammensætning til oprensning af jord | |
DK2068927T3 (da) | Fremgangsmåder til reducering af eosinofilniveauer | |
BRPI0920284A2 (pt) | composição e método | |
DK2570467T3 (da) | Sammensætninger af tetrafluorpropen og carbonhydrider | |
BRPI0814359A2 (pt) | Método | |
BRPI0817226A2 (pt) | Método | |
BRPI0810634A2 (pt) | Composições fungicidas | |
BRPI0813775A2 (pt) | Composição | |
BRPI0817726A2 (pt) | Método | |
BRPI0906722A2 (pt) | Métodos e composições usando polipeptídeos de fusão klotho-fgf | |
BRPI0809573A8 (pt) | composição, e, método | |
ATE528048T1 (de) | Schweisshemmende/desodorierende zusammensetzung | |
DK2323638T3 (da) | Sammensætninger og fremgangsmåder til behandling af osteoartritis | |
DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
BRPI0810557A2 (pt) | composição | |
BRPI0811274A2 (pt) | Composição | |
BRPI0814167A2 (pt) | Composição, e, método | |
DK2222314T3 (da) | Anvendelser og midler til opnåelse af bronchorelaxation | |
DK3263112T3 (da) | Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer | |
BRPI0809678A2 (pt) | Métodos | |
BRPI0814748A2 (pt) | Compostos de alditóis substituídos, composições e métodos | |
DK2187967T3 (da) | Fremgangsmåde og sammensætninger til behandling af cancere |